Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial
Yan-Ling Zhang, Peng Ou, Xiang-Hang Lu, Yan-Ping Chen, Jun-Mei Xu, Ru-Ping Dai, Yan-Ling Zhang, Peng Ou, Xiang-Hang Lu, Yan-Ping Chen, Jun-Mei Xu, Ru-Ping Dai
Abstract
Background: Remifentanil, an ultra-short-acting opioid, is widely used for pain control during surgery. However, regular dose (RD) remifentanil exacerbates postoperative pain in a dose-dependent manner. Recent studies suggest that high-dose (HD) remifentanil offers sustained analgesia in experimental studies. We thus hypothesized that intraoperative administration of high-dose remifentanil may attenuate postoperative pain.
Methods: In this prospective, randomized, double blind, controlled clinical study, sixty patients undergoing thyroidectomy (18-60 years-of-age) received an intraoperative infusion of 0.2 (RD group) or 1.2 μg kg(-1) min(-1) (HD group) remifentanil during thyroidectomy. A visual analogue scale (VAS) was used to measure pain intensity. Mechanical pain threshold on the forearm was assessed using von Frey filaments before surgery (baseline), 2 h postoperatively and 18-24 h postoperatively. The primary outcome was to compare the difference of VAS score at different time points after operation and morphine consumption 24 h postoperatively between RD and HD groups. The second outcome was to compare the difference of mechanical pain thresholds in the forearm postoperatively between RD and the HD groups.
Results: VAS scores were lower 30 min postoperatively in the HD group (1.29 ± 1.67, 95% CI 0.64-1.94) compared with the RD group (2.21 ± 1.67, 95% CI 1.57-2.84) (t = 3.427, p = 0.0043, RD group vs. HD group). Postoperative morphine consumption was much lower in the HD group compared with the RD group (1.27 ± 1.88 mg vs. 0.35 ± 1.25 mg, p = 0.033). In both groups, mechanical pain threshold was decreased 18-24 h postoperatively (2.93 ± 0.209 Ln(g) vs. 3.454 ± 2.072 Ln(g), p = 0.032 in RD group; 2.910 ± 0.196 Ln(g) vs. 3.621 ± 0.198 Ln(g), p = 0.006 in HD group, 18-24 h postoperatively vs baseline).
Conclusions: Intraoperative administration of high-dose remifentanil decreased VAS scores and morphine consumption postoperatively. Thus, modulation of intraoperative opiates may be a simple and effective method of postoperative pain management.
Trial registration: This trial is registered in ClinicalTrials.gov, with the Name: Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy, and ID number: NCT01761149.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Angst MS, Clark JD (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104: 570–87.
- Chang G, Chen L, Mao J (2007) Opioid tolerance and hyperalgesia. Med Clin North Am 91: 199–211.
- Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, et al. (2005) Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103: 147–55.
- Song JW, Lee YW, Yoon KB, Park SJ, Shim YH (2011) Magnesium sulfate prevents remifentanil-induced postoperative hyperalgesia in patients undergoing thyroidectomy. Anesth Analg 113: 390–7.
- Kim SH, Lee MH, Seo H, Lee IG, Hong JY, et al. (2013) Intraoperative infusion of 0.6–0.9 μg·kg(−1)·min(−1) remifentanil induces acute tolerance in young children after laparoscopic ureteroneocystostomy. Anesthesiology 118: 337–43.
- Drdla-Schutting R, Benrath J, Wunderbaldinger G, Sandkuhler J (2012) Erasure of a spinal memory trace of pain by a brief, high-dose opioid administration. Science 335: 235–8.
- Manering NA, Reuter T, Ihmsen H, Yeomans DC, Tzabazis A (2013) High-dose remifentanil prevents development of thermal hyperalgesia in a neuropathic pain model. Br J Anaesth 110: 287–92.
- Mills C, Leblond D, Joshi S, Zhu C, Hsieh G, et al. (2012) Estimating efficacy and drug ED50’s using von Frey thresholds: impact of weber’s law and log transformation. J Pain 13: 519–23.
- Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659–61.
- Burkle H, Dunbar S, Van Aken H (1996) Remifentanil: a novel, short-acting, mu-opioid. Anesth Analg 83: 646–51.
- Echevarria G, Elgueta F, Fierro C, Bugedo D, Faba G (2011) Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br J Anaesth 107: 959–65.
- Schmidt S, Bethge C, Forster MH, Schafer M (2007) Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain 23: 605–11.
- Drdla R, Gassner M, Gingl E, Sandkuhler J (2009) Induction of synaptic long-term potentiation after opioid withdrawal. Science 325: 207–10.
- Zhao M, Joo DT (2008) Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 109: 308–17.
- Zahn PK, Pogatzki-Zahn EM, Brennan TJ (2005) Spinal administration of MK-801 and NBQX demonstrates NMDA-independent dorsal horn sensitization in incisional pain. Pain 114: 499–510.
- Pogatzki-Zahn EM, Zahn PK, Brennan TJ (2007) Postoperative pain–clinical implications of basic research. Best Pract Res Clin Anaesthesiol 21: 3–13.
- Singler B, Troster A, Manering N, Schuttler J, Koppert W (2007) Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg 104: 1397–403.
- Cheng SS, Yeh J, Flood P (2008) Anesthesia matters: patients anesthetized with propofol have less postoperative pain than those anesthetized with isoflurane. Anesth Analg 106: 264–9.
Source: PubMed